Family History of Cancers Increases Risk of Renal Cell Carcinoma in a Chinese Population
- PMID: 36065260
- PMCID: PMC9440662
- DOI: 10.2147/CMAR.S376784
Family History of Cancers Increases Risk of Renal Cell Carcinoma in a Chinese Population
Abstract
Purpose: To explore the impact of family history (FH) on renal cell carcinoma (RCC) and its pathological subtype clear cell RCC (ccRCC) in a Chinese population; a significant association has previously been determined not only in familial cancer syndrome but also in sporadic cases in western populations.
Methods: Consecutive patients with kidney tumors from October 2017 to May 2021 at a tertiary hospital in Shanghai were enrolled in the study. Demographic and clinical information was collected, including age, gender, FH (positive or negative, types of cancers, degree of relatives, etc.), pathological diagnosis, and Fuhrman grades.
Results: A positive FH of any cancer was observed in 26.5% of the RCC patients, while only 16.8% patients with benign kidney tumor were found to have a positive FH. A strong correlation was observed between FH of any cancers in first-degree relatives and RCC (odds ratio [OR]=4.60, 95% confidence interval [CI]: 1.95-10.85, P=5.50×10-5) or ccRCC (OR=4.63, 95% CI: 1.95-11.02, P=9.63×10-5). In subgroup analysis, FH of digestive cancers was significantly associated with RCC (OR=4.42, 95% CI: 1.35-14.51, P=0.005) or ccRCC (OR=4.14, 95% CI: 1.25-13.75, P=6.84×10-4). Similar results were found in multivariate analyses. However, no significant association was observed between FH and age at onset.
Conclusion: FH was an independent risk factor for RCC and ccRCC in this Chinese population. FH of any cancer in first-degree relatives and FH of digestive cancers were found to be the most significant risk factors for kidney cancers.
Keywords: Chinese population; family history; multivariate regression analysis; renal cell carcinoma; risk factor.
© 2022 Xing et al.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures


Similar articles
-
[Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Aug 18;53(4):640-646. doi: 10.19723/j.issn.1671-167X.2021.04.003. Beijing Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 34393221 Free PMC article. Chinese.
-
Family history and risk of renal cell carcinoma.Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):1001-4. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11535554
-
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.Dan Med J. 2017 Oct;64(10):B5339. Dan Med J. 2017. PMID: 28975890
-
Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma.Hum Pathol. 2022 Jun;124:36-44. doi: 10.1016/j.humpath.2022.03.002. Epub 2022 Mar 16. Hum Pathol. 2022. PMID: 35306021 Review.
-
[Heredity in renal and prostatic neoplasia].Arch Ital Urol Androl. 1997 Sep;69(4):241-6. Arch Ital Urol Androl. 1997. PMID: 9417296 Review. Italian.
References
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous